OrthoXel is a growing, dynamic, young company working specifically in the field of orthopaedic trauma, currently highly focused on intramedullary nail systems. The first device that OrthoXel has been working on is the Apex Tibial Nailing System. The Apex Tibial Nailing System was recently awarded FDA 510(k) approval and the CE Mark, for commercialization in the US and European markets respectively. Click here for full Press Release.
The basic R&D and proof of principle for the Apex Nailing System was completed in the OrthoXel home city of Cork, Ireland at the Cork Institute of Technology’s MEDIC centre over a five-year development process. This work included iterative design-build-test activities, bench testing, cadaver studies, and a GLP-controlled pre-clinical study. OrthoXel is delighted to announce that the world’s first patient implantation with the Apex Tibial Nailing System has been successfully completed by Professor James Harty, Consultant Orthopaedic Surgeon and Head of the Department of Orthopaedics at Cork University Hospital. For the full press release, click here.
In the past nine months the OrthoXel team has doubled in size. Ahead of the Irish Prime Minister’s visit to the USA to promote US & Irish Trade Relations, OrthoXel was delighted to be exhibiting at the American Association of Orthopaedic Surgeons 2018 Annual Meeting in New Orleans, to showcase the Apex tibial Nailing System and to start securing commercial and clinical partners for the United States. If you’re interested in working together, or have any queries contact us.
Pictured is some of the OrthoXel team at AAOS 2018. Left to right: James Harty, Pat O’Connor, Hannah Dailey, Charles Daly.